The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center
Catheterization and Cardiovascular Interventions2019Vol. 96(2), pp. 442–447
Citations Over TimeTop 10% of 2019 papers
Najdat Bazarbashi, Keerat Rai Ahuja, Mohamed M. Gad, Yasser Sammour, Manpreet Kaur, Antonette Karrthik, Anas M. Saad, Shameer Khubber, Kamalpreet Dhaliwal, Stephanie L. Mick, José Navia, Rishi Puri, Grant W. Reed, Amar Krishnaswamy, Samir Kapadia
Abstract
Single 6F ProGlide use for preclosure is a safe strategy for TF TAVR using the S3 valve. Additional closure device was not needed in almost one-quarter of the patients. When necessary, residual bleeding can be controlled with the AngioSeal Device at the end of the procedure. This single device preclose strategy can help to reduce the cost of TAVR procedure without increasing risk.
Related Papers
- → Radial artery pseudoaneurysm as a rare very late complication of transradial cardiac catheterization(2020)3 cited
- → Off-label use of Angio-Seal vascular closure device for the repair of femoral pseudoaneurysm after transfemoral coronary intervention(2019)4 cited
- → TCTAP A-090 Extra Vascular Access Closure in Anti-Coagulated Patients Under Going Percutaneous Interventions(2015)
- → Novel vascular sealing device for closure of percutaneous vascular access sites(1998)